The use of Remdesivir, the drug developed by Gilead for the treatment of Covid-19, is able to reduce the number of ICU patients by more than 17000 units and, potentially, prevent about 7000 deaths in 5 months. These are the results of the application of a model developed by a team of health economists from...Read More